Literature DB >> 30138176

Update on Perioperative Acute Kidney Injury.

Alexander Zarbock1, Jay L Koyner2, Eric A J Hoste3, John A Kellum4.   

Abstract

Acute kidney injury (AKI) in the perioperative period is a common complication and is associated with increased morbidity and mortality. A standard definition and staging system for AKI has been developed, incorporating a reduction of the urine output and/or an increase of serum creatinine. Novel biomarkers may detect kidney damage in the absence of a change in function and can also predict the development of AKI. Several specific considerations for AKI risk are important in surgical patients. The surgery, especially major and emergency procedures in critically ill patients, may cause AKI. In addition, certain comorbidities, such as chronic kidney disease and chronic heart failure, are important risk factors for AKI. Diuretics, contrast agents, and nephrotoxic drugs are commonly used in the perioperative period and may result in a significant amount of in-hospital AKI. Before and during surgery, anesthetists are supposed to optimize the patient, including preventing and treating a hypovolemia and correcting an anemia. Intraoperative episodes of hypotension have to be avoided because even short periods of hypotension are associated with an increased risk of AKI. During the intraoperative period, urine output might be reduced in the absence of kidney injury or the presence of kidney injury with or without fluid responsiveness. Therefore, fluids should be used carefully to avoid hypovolemia and hypervolemia. The Kidney Disease: Improving Global Outcomes guidelines suggest implementing preventive strategies in high-risk patients, which include optimization of hemodynamics, restoration of the circulating volume, institution of functional hemodynamic monitoring, and avoidance of nephrotoxic agents and hyperglycemia. Two recently published studies found that implementing this bundle in high-risk patients reduced the occurrence of AKI in the perioperative period. In addition, the application of remote ischemic preconditioning has been studied to potentially reduce the incidence of perioperative AKI. This review discusses the epidemiology and pathophysiology of surgery-associated AKI, highlights the importance of intraoperative oliguria, and emphasizes potential preventive strategies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30138176     DOI: 10.1213/ANE.0000000000003741

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  25 in total

1.  [Impact of oliguria during lung surgery on postoperative acute kidney injury].

Authors:  Z T Meng; D L Mu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-24

2.  Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).

Authors:  Alessandro Tafuri; Michele Marchioni; Clara Cerrato; Andrea Mari; Riccardo Tellini; Katia Odorizzi; Alessandro Veccia; Daniele Amparore; Aliasger Shakir; Umberto Carbonara; Andrea Panunzio; Federica Trovato; Michele Catellani; Letizia M I Janello; Lorenzo Bianchi; Giacomo Novara; Fabrizio Dal Moro; Riccardo Schiavina; Elisa De Lorenzis; Paolo Parma; Sebastiano Cimino; Ottavio De Cobelli; Francesco Maiorino; Pierluigi Bove; Fabio Crocerossa; Francesco Cantiello; David D'Andrea; Federica Di Cosmo; Francesco Porpiglia; Pasquale Ditonno; Emanuele Montanari; Francesco Soria; Paolo Gontero; Giovanni Liguori; Carlo Trombetta; Guglielmo Mantica; Marco Borghesi; Carlo Terrone; Francesco Del Giudice; Alessandro Sciarra; Andrea Galosi; Marco Moschini; Shahrokh F Shariat; Marta Di Nicola; Andrea Minervini; Matteo Ferro; Maria Angela Cerruto; Luigi Schips; Vincenzo Pagliarulo; Alessandro Antonelli
Journal:  World J Urol       Date:  2022-10-06       Impact factor: 3.661

3.  Postoperative AKI.

Authors:  Naomi Boyer; Jack Eldridge; John R Prowle; Lui G Forni
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-16       Impact factor: 10.614

4.  Preoperative NT-proBNP and LVEF for the prediction of acute kidney injury after noncardiac surgery: a single-centre retrospective study.

Authors:  Jiaqi Wang; Yehong Dong; Bingcheng Zhao; Kexuan Liu
Journal:  BMC Anesthesiol       Date:  2022-06-24       Impact factor: 2.376

Review 5.  Perioperative Pain Management and Opioid Stewardship: A Practical Guide.

Authors:  Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary
Journal:  Healthcare (Basel)       Date:  2021-03-16

Review 6.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

7.  Effect of pneumoperitoneum pressure and the depth of neuromuscular block on renal function in patients with diabetes undergoing laparoscopic pelvic surgery: study protocol for a double-blinded 2 × 2 factorial randomized controlled trial.

Authors:  Xiaohan Xu; Yahong Gong; Yuelun Zhang; Jiaxin Lang; Yuguang Huang
Journal:  Trials       Date:  2020-06-29       Impact factor: 2.279

8.  Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis.

Authors:  Mariateresa Giglio; Lidia Dalfino; Filomena Puntillo; Nicola Brienza
Journal:  Crit Care       Date:  2019-06-26       Impact factor: 9.097

9.  Meta-analysis of AKI to CKD transition in perioperative patients.

Authors:  Pedro M Abdala; Elizabeth A Swanson; Michael P Hutchens
Journal:  Perioper Med (Lond)       Date:  2021-06-29

10.  Annexin A1 Tripeptide Mimetic Increases Sirtuin-3 and Augments Mitochondrial Function to Limit Ischemic Kidney Injury.

Authors:  Hagir Suliman; Qing Ma; Zhiquan Zhang; Jiafa Ren; Benjamin T Morris; Steven D Crowley; Luis Ulloa; Jamie R Privratsky
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.